Latanoprost Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Comparison of Efficacy and Ocular Surface Disease Assessment Between Monoprost and BAK-preserved Latanoprost
Conditions:   Glaucoma;   Ocular Hypertension Interventions:   Drug: Monoprost;   Drug: Xalatan Sponsors:   CHA University;   Samil Pharmaceutical Co., Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2021 Category: Research Source Type: clinical trials

Prospective, Single Center Switching Study of 0.0015% Tafluprost Ophthalmic Solution in Primary Open-angle Glaucoma and Ocular Hypertension Patients With Corneal Disorders (Switching From 0.005% Latanoprost Ophthalmic Solution)
Condition:   Glaucoma, Primary Open Angle Interventions:   Drug: Latanoprost;   Drug: tafluprost Sponsor:   Santen Pharmaceutical (Taiwan) Co., LTD Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 4, 2021 Category: Research Source Type: clinical trials